Wuxi Biologics Inc., of Shanghai, entered a partnership to manufacture protein-based therapeutics for Inhibrx Inc., of La Jolla, Calif. Under the partnership, Inhibrx will use Wuxi exclusively for any human biologic therapeutics projects that are started within the next three years.